Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAngle Regulatory News (AGL)

  • There is currently no data for AGL

Rule 8.3-Angle Plc

12 May 2008 13:20

RNS Number : 2093U
Kaupthing Bank hf
12 May 2008
 
FORM 8.3
DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE
(Rule 8.3 of the Takeover Code)
 
 
1. KEY INFORMATION
 
Name of person dealing (Note 1)
Kaupthing Bank hf
Company dealt in
Angle Plc
Class of relevant security to which the dealings being disclosed relate(Note 2)
Ordinary Shares
Date of dealing
09 May 2008
 
 
2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE
 
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
 
 
 
Long
Short
 
 
Number (%)
Number (%)
(1) Relevant securities
 
 
9,418 (0.03%)
(2) Derivatives (other than options)
 
1,017,125 (3.75 %)
 
1,017,125 (3.75 %)
 
(3) Options and agreements to purchase/sell
 
 
 
Total
 
1,017,707 (3.75 %)
 
1,026,543 (3.78 %)
 
 
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
 
Class of relevant security:
 
Long
Short
 
 
Number (%)
Number (%)
(1) Relevant securities
 
 
 
(2) Derivatives (other than options)
 
 
 
(3) Options and agreements to purchase/sell
 
 
 
Total
 
 
 
 
(c) Rights to subscribe (Note 3)
 
Class of relevant security:
 
Details
 
 
 
 
 
3. DEALINGS (Note 4)
 
(a) Purchases and sales 
 
Purchase/sale
 
Number of securities
Price per unit (Note 5)
Sell
10,000
39.50p
 
 
 
 (b) Derivatives transactions (other than options)
 
Product name,
e.g. CFD
Long/short (Note 6)
Number of securities (Note 7)
Price per unit (Note 5)
 
 
 
 
 
 
 
 
 
 
(c) Options transactions in respect of existing securities
(i) Writing, selling, purchasing or varying
 
Product name,
e.g. call option
 
Writing, selling, purchasing, varying etc.
Number of securities to which the option relates (Note 7)
Exercise
price
Type, e.g. American, European etc.
Expiry
date
Option money
paid/received per unit (Note 5)
 
 
 
 
 
 
 
 
 
 
 
 
(ii) Exercising
 
Product name, e.g. call option
Number of securities
Exercise price per unit (Note 5)
 
 
 
 
 
 
(d) Other dealings (including new securities) (Note 4)
 
Nature of transaction (Note 8)
 
Details
Price per unit (if applicable)(Note 5)
 
 
 
 
 
 
4. OTHER INFORMATION
 
Agreements, arrangements or understandings relating to options or derivatives
 
 
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated. 
No voting rights on CFD holdings
 
 
 
Is a Supplemental Form 8 attached? (Note 9) NO
 
 
Date of disclosure
12 May 2008
Contact name
Richard Easton
Telephone number
0203 205 6620
If a connected EFM, name of offeree/offeror with which connected
 
If a connected EFM, state nature of connection (Note 10)
 
 
 
Notes
 
The Notes on Form 8.3 can be viewed on the Takeover Panel’s website at www.thetakeoverpanel.org.uk
 
 
This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RETXLLFFVEBFBBD
Date   Source Headline
31st Mar 20063:54 pmRNSBoard Change
31st Mar 20063:52 pmRNSHolding(s) in Company
29th Mar 200611:45 amRNSEGM Statement
29th Mar 20067:02 amRNSNew Venture Company
6th Mar 20067:02 amRNSPlacing
24th Jan 20067:01 amRNSChange of Adviser
24th Jan 20067:01 amRNSContract Extension
24th Jan 20067:01 amRNSInterim Results
16th Dec 20052:32 pmRNSSnr Appt at Geomerics
17th Nov 20057:02 amRNSRe US Venture -- Aberro
15th Nov 20057:03 amRNSRe Synature Ltd
11th Nov 20057:29 amRNSAppointment at Novocellus Ltd
2nd Nov 20059:41 amRNSDirector/PDMR Shareholding
25th Oct 20058:00 amRNSAppointments - UK Ventures
20th Oct 20057:00 amRNSContract Extension
17th Oct 20057:01 amRNSVentures (US) Team Expansion
1st Sep 200512:43 pmRNSHolding(s) in Company
25th Aug 20053:02 pmRNSResult of AGM
11th Aug 20055:21 pmRNSAdditional Listing
1st Aug 20057:01 amRNSDirectorate Change
20th Jul 20058:30 amRNSContract Win
6th Jul 20057:01 amRNSFinal Results
24th Jun 20058:00 amRNSRe Provexis Admission to AIM
23rd Jun 20053:13 pmRNSNotice of Results
22nd Jun 200512:45 pmRNSHolding(s) in Company
10th Jun 20057:01 amRNSJoint Research Programme
31st May 20057:02 amRNSRe Acolyte Biomedica
26th May 20057:02 amRNSTrading Update
26th May 20057:02 amRNSProvexis - Reverse Takeover
6th May 20057:00 amRNSGeomerics - New Venture Co.
29th Apr 20057:01 amRNSNew US Venture
12th Apr 20057:00 amRNSNew Contracts
23rd Mar 200512:03 pmRNSRe Provexis Limited
21st Mar 20058:51 amRNSAdditional Listing
10th Mar 200512:06 pmRNSDirector Appt to UK Ventures
18th Feb 20058:52 amRNSProvexis Reverse Takeover
11th Feb 20057:00 amRNSNew Venture Company
10th Feb 20051:30 pmRNSHolding(s) in Company
20th Jan 20057:01 amRNSNew Agreement
20th Jan 20057:00 amRNSInterim Results
18th Jan 20057:00 amRNSLaunch of US Ventures
17th Jan 200510:47 amRNSAssociate Director Appointed
7th Jan 200510:44 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.